Acetaminophen (APAP) overdose is a leading cause of acute liver failure worldwide, in which mitochondrial DNA (mtDNA) released by damaged hepatocytes activates neutrophils through binding of Toll-like receptor 9 (TLR9), further aggravating liver injury. Here, we demonstrated that mtDNA/TLR9 also activates a negative feedback pathway through induction of microRNA-223 (miR-223) to limit neutrophil overactivation and liver injury. After injection of APAP in mice, levels of miR-223, the most abundant miRNAs in neutrophils, were highly elevated in neutrophils. Disruption of the miR-223 gene exacerbated APAP-induced hepatic neutrophil infiltration, oxidative stress, and injury and enhanced TLR9 ligand-mediated activation of proinflammatory mediators in neutrophils. An additional deletion of the intercellular adhesion molecule 1 (ICAM-1) gene ameliorated APAP-induced neutrophil infiltration and liver injury in miR-223 knockout mice. In vitro experiments revealed that miR-223-deficient neutrophils were more susceptible to TLR9 agonist-mediated induction of proinflammatory mediators and nuclear factor kappa B (NF-jB) signaling, whereas overexpression of miR-223 attenuated these effects in neutrophils. Moreover, inhibition of TLR9 signaling by either treatment with a TLR9 inhibitor or by disruption of TLR9 gene partially, but significantly, suppressed miR-223 expression in neutrophils post-APAP injection. In contrast, activation of TLR9 up-regulated miR-223 expression in neutrophils in vivo and in vitro. Mechanistically, activation of TLR9 up-regulated miR-223 by enhancing NF-jB binding on miR-223 promoter, whereas miR-223 attenuated TLR9/NF-jB-mediated inflammation by targeting IjB kinase a expression. Collectively, up-regulation of miR-223 plays a key role in terminating the acute neutrophilic response and is a therapeutic target for treatment of APAP-induced liver failure. (HEPATOLOGY 2017;66:220-234).
A cetaminophen (APAP) is one of the most commonly used antipyretic and analgesic, but its overdose is also a leading cause of acute liver failure.
(1) APAP is metabolized by hepatic cytochrome P450 2E1 (CYP2E1) into a powerful electrophilic intermediate N-acetyl-p-benzoquinoneimine (NAPQI), which is detoxified by glutathione (GSH). However, excessive NAPQI depletes hepatic GSH and subsequently leads to oxidative stress reactions, mitochondrial DNA (mtDNA) damage, finally Abbreviations: ALT, alanine aminotransferase; APAP, acetaminophen; AST, aspartate aminotransferase; ChIP, chromatin immunoprecipitation; Cit-H3, citrullination of histone 3; CYP2E1, cytochrome P450 2E1; dKO, double knockout; GSH, glutathione; H&E, hematoxylin and eosin; 4-HNE, 4-hydroxynonenal; HNF-1a, hepatocyte nuclear factor 1 alpha; ICAM-1, intercellular adhesion molecule 1; IHC, immunohistochemistry; IKKa, IjB kinase a; IL, interleukin; iNOS, inducible nitric oxide synthase; IRAK1, IL-1 receptor-associated kinase 1; IFN-c, interferon-gamma; LPS, lipopolysaccharide; MCP-1, monocyte chemotactic protein 1; MIP, macrophage inflammatory protein; miRNAs, microRNAs; miR-223, microRNA-223; miR-223KO, miR-223 knockout; NO, nitric oxide; MPs, microparticles; MPO, myeloperoxidase; mtDNA, mitochondrial DNA; NALP3, NACHT, LRR, and PYD domains-containing protein 3; NAPQI, N-acetyl-p-benzoquinone-imine; NETs, neutrophils extracellular traps; NF-jB, nuclear factor kappa B; NKT, natural killer T; NLRP3, NLR family pyrin domain-containing 3; NS-miRNA, nonspecific miRNA; PBS, phosphate-buffered saline; p-JNK, phosphorylated c-Jun N-terminal kinase; poly I:C, polyinosinic:polycytidylic acid; ROS, reactive oxygen species; SOD, superoxide dismutase; STAT3, signal transducer and activator of transcription 3; TLR9, Toll-like receptor 9; TNF, tumor necrosis factor; TRAF, TNF receptor-associated factor; 3 0 -UTR, 3 0 -untranslated region; VCAM-1, vascular cell adhesion molecule 1; WT, wild type resulting in hepatocyte death. (1, 2) In addition to APAPinduced direct hepatotoxicity, proinflammatory and anti-inflammatory cascades of the innate immune system are simultaneously activated, the balance of which may further influence progression and severity of APAP-induced liver injury. (3) (4) (5) (6) For example, investigators have demonstrated that during APAP-induced liver injury, necrotic hepatocytes release mtDNA, which acts as an agonist for Toll-like receptor 9 (TLR9) to induce neutrophil infiltration and liver inflammation that may further exacerbate hepatocellular damage. (7) (8) (9) In addition, the pathological role of TLR9 activation in inducing neutrophil infiltration and liver injury has also been reported in other liver injury models, including liver ischemia/reperfusion, (10) (11) (12) chronic-plus-binge ethanol feeding, (13) nonalcoholic fatty liver disease, (14) and hepatitis B surface antigen transgenic mice. (15) However, how the inflammation is terminated in APAP-induced hepatotoxicity remains largely unknown.
MicroRNAs (miRNAs) are endogenous, small, noncoding RNAs of 22 nucleotides in length that regulate entire intracellular pathways at a posttranscriptional level by specifically binding with the 3 0 -untranslated region (3 0 -UTR) of target gene mRNAs. (16) Several recent studies reported that a large number of miRNAs were elevated in serum in mice and patients post-APAP administration, (17) (18) (19) (20) (21) but the role of miRNAs in APAPinduced liver injury has not been investigated. In the current study, to understand the mechanisms by which neutrophilic inflammation is controlled during APAPinduced liver injury, we were particularly interested in neutrophil-specific miR-223 that was initially reported to regulate the early and late stages of granulopoiesis as well as in homeostasis of mature neutrophils. (22) Subsequent studies suggest that miR-223 acts as an antiinflammatory mediator, playing an important role in the pathogenesis of various types of diseases. (23, 24) In addition, miR-223 has also been found to control liver cell proliferation, survival, and cholesterol metabolism in hepatocytes as well as neutrophil functions by targeting a variety of genes. (25) (26) (27) (28) In the current study, we found that miR-223 expression was highly elevated in neutrophils post-APAP injection, and that deletion of miR-223 exacerbated APAP-induced neutrophil infiltration, liver injury, and inflammation. Upregulation of miR-223 was partially dependent on TLR9 activation in APAP-induced liver injury. Mechanistic studies suggest that damaged hepatocytes release hepatic mtDNA, which up-regulates miR-223 in neutrophils by activation of TLR9, forming a negative feedback loop to control APAP-induced neutrophilic inflammation and, subsequently, terminating liver inflammation. -/-mice on a C57BL/6 background were kindly provided by Dr. Giorgio Trinchieri (NCI, Frederick, MD). All mice were maintained in a specific pathogen-free facility and were cared for in accord with NIH guidelines. The study was approved by the NIAAA Animal Care and Use Committee.
Materials and Methods

MICE
APAP-INDUCED LIVER INJURY
Fresh solutions of APAP (Sigma-Aldrich, St. Louis, MO) were prepared immediately before use by dissolving the compound in warmed phosphate-buffered saline (PBS). All mice were intraperitoneally injected with 350 mg/kg of APAP after overnight fasting or without fasting. Liver and blood samples were collected at various time points post-APAP injection.
TLR9 AGONIST AND ANTAGONIST INJECTION
Male mice (body weight, 20-22 g) were intravenously injected with TLR9 agonist (ODN 1585; Invivogen, CA) or TLR9 agonist control (ODN 1585 control; Invivogen, CA) at a dose of 50 lg/mouse. Liver and blood samples were collected 6 hours postinjection, and neutrophils from liver and blood samples were isolated and subjected to RT-PCR analysis. TLR9 antagonist (ODN 2088; Invivogen, CA) was also used to block TLR9 as described. 
STATISTICAL ANALYSIS
Data are expressed as the means 6 SEM for each group and were analyzed using GraphPad Prism software (v. 5.0a; GraphPad Software Inc., La Jolla, CA).
To compare values obtained from two groups, the Student t test was performed. P values of <0.05 were considered significant.
Further details of the materials and methods are provided in the Supporting Information.
Results
UP-REGULATION OF miR-223 EXPRESSION IN NEUTROPHILS IN MICE POST-APAP TREATMENT
To understand the mechanisms by which hepatic neutrophil infiltration is regulated during APAPinduced liver injury, we examined serum and hepatic miR-223 expression, an miRNA that was known to regulate neutrophil functions. (22) Hepatic and serum levels of miR-223 were significantly elevated 6 or 24 hours post-APAP treatment (Fig. 1A) . Furthermore, miR-223 expression was markedly up-regulated in neutrophils from liver and blood 6 and 24 hours post-APAP injection (Fig. 1A) . Northern blot assay further confirmed up-regulation of miR-223 expression in hepatic neutrophils and circulating neutrophils from APAP-treated mice (Supporting Fig. S1 ).
DELETION OF miR-223 EXACERBATES APAP-INDUCED LIVER INJURY
To better understand the function of miR-223 in APAP-induced liver inflammation and injury, WT and miR-223KO mice were used and treated with APAP. miR-223 deletion in miR-223KO mice was confirmed by RT-qPCR analyses as shown in Supporting Fig. S2 . Compared to WT mice, overnightfasted miR-223KO mice showed much higher levels of serum alanine aminotransferase (ALT) and aspartate aminotransferease (AST) 6 and 24 hours post-APAP injection (Fig. 1B) . In addition, hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC) analyses revealed miR-223KO mice had larger areas of liver necrosis and a greater degree of hepatic neutrophil and macrophage infiltration than WT mice (Supporting Fig. S3A-C) .
To test whether the increased susceptibility of miR-223KO mice to APAP-induced liver injury was attributed to alteration of APAP metabolism, we examined expression of CYP2E1, a major metabolizing enzyme in bioactivation of APAP into NAPQI. (29) Interestingly, IHC staining and real-time qPCR analyses demonstrated that levels of hepatic CYP2E1 protein, activity, and mRNA were much higher in miR-223KO mice compared to those in WT mice after overnight fasting (Fig. 1C,D and Supporting Fig. S4A ). However, no differences were observed between nonfasted WT and miR-223KO groups (Fig. 1C,D and Supporting Fig. S4A ).
Expression and activity of CYP2E1 were reported to be regulated by several transcription factors, such as b-catenin, (30) nuclear factor kappa B (NF-jB), (31) and hepatocyte nuclear factor 1 alpha (HNF-1a). (32) Here, we observed that hepatic b-catenin protein expression was significantly higher in miR-223KO mice compared to WT mice after overnight fasting. In contrast, no differences in hepatic NF-jB p65 and HNF1a proteins were observed in WT and miR-223KO mice after overnight fasting (Supporting Fig. S4B ). These data indicated that b-catenin may be involved in up-regulation of CYP2E1 in miR-223KO mice after overnight fasting, which may cause increased susceptibility of miR-223KO mice to APAP hepatotoxicity.
To rule out the involvement of CYP2E1 dysregulation in the increased susceptibility of miR-223KO mice to APAP-induced liver injury, we treated WT and miR-223KO mice with APAP without overnight fasting, a condition that does not affect hepatic expression of CYP2E1 in miR-223KO and WT mice (as 2) in miR-223KO mice was much higher than that in WT mice post-APAP injection (Fig. 2C) .
miR-223 has been implicated in regulating Fasinduced hepatocyte death. (25) Thus, we wondered whether miR-223 in hepatocytes also affects APAPinduced cell death. To answer this question, the direct role of miR-223 in APAP-induced hepatocyte apoptosis was defined in cultured hepatocytes. Deletion of 1 neutrophils in liver were determined, and serum ALT levels were measured. Values represent means 6 SEM (n 5 6 in panels A-C; n 5 7 in panel D). *P < 0.05; **P < 0.01; ***P < 0.001. miR-223 or overexpression of miR-223 in hepatocytes did not significantly affect APAP-induced hepatocyte death (Supporting Fig. S7A,B) .
To further confirm whether neutrophil infiltration contributes to enhanced liver injury in miR-223KO mice post-APAP injection, we performed an additional deletion of the ICAM-1 gene (a key factor for neutrophil infiltration in APAP hepatotoxicity (33) ) in miR-223KO mice to reduce neutrophil infiltration. An additional deletion of ICAM-1 markedly reduced hepatic neutrophil number in APAP-treated dKO mice compared to miR-223KO mice (Fig. 2D) . Moreover, dKO mice had much lower serum ALT levels than WT mice post-APAP injection. These findings strongly suggest that neutrophils contribute to APAPinduced liver injury in miR-223KO mice.
Next, we examined whether miR-223 and ICAM-1 reciprocally regulated each other. Expression of ICAM-1 mRNAs in liver and neutrophils was comparable in WT and miR-223KO mice, suggesting that ICAM-1 is not a direct target of miR-223 (Supporting Fig. S8A ). Interestingly, expression of miR-223 in liver and neutrophils was significantly higher in ICAM-1KO mice than in WT mice (Supporting Fig.  S8B ), indicating that deletion of the ICAM-1 gene affects miR-223 expression. The underlying mechanisms by which ICAM-1 deletion alters miR-223 expression in neutrophils remain unknown and need further studies to be explored.
In summary, miR-223KO mice are more susceptible to APAP-induced liver injury with or without fasting. Because hepatic expression of CYP2E1 protein is comparable in miR-223KO and WT mice without fasting, nonfasted WT and nonfasted miR-223KO mice were used in the rest of the study.
miR-223KO MICE ARE MORE SUSCEPTIBLE TO APAP-INDUCED OXIDATIVE STRESS
To further examine the mechanisms by which miR-223KO mice are more susceptible to APAP-induced liver injury, hepatic oxidative stress and its related genes were examined. Before the APAP injection, hepatic levels of GSH, an important antioxidant, were comparable between WT and miR-223KO mice (Fig.  3A) . Injection of APAP rapidly down-regulated GSH levels to a much greater degree in miR-223KO mice than that in WT mice 3 hours post-APAP challenge. Hepatic levels of 4-HNE (4-hydroxynonenal; oxidative stress markers) were higher in APAP-treated miR-223KO mice compared to WT mice (Fig. 3B) . Notably, N-nitrotyrosine, which is a reactive nitrogen species formed by the very rapid reaction of superoxide and nitric oxide (NO), (34) was also higher in miR-223KO mice compared to WT mice post-APAP treatment (Fig. 3B) . Additionally, inducible nitric oxide synthase (iNOS), which was reported to promote hepatocytes death by generating the high amount of NO, (35, 36) was up-regulated in liver of miR-223KO mice compared to that of WT mice 24 hours post-APAP injection (Fig. 3C) . Finally, hepatic expression of activated phosphorylated c-Jun N-terminal kinase (p-JNK), which is known to play an important role in APAP-associated oxidative stress, (37) was significantly higher in miR-223KO mice 6 hours post-APAP injection compared to WT mice (Fig. 3B ).
In addition, hepatic expression of superoxide dismutase (SOD) 1, a reactive oxygen species (ROS) detoxification gene, was lower in APAP-treated miR-223KO mice compared to WT mice, whereas hepatic expression of other ROS detoxification genes, such as SOD-2 and catalase, were comparable between WT and miR-223KO mice (Fig. 3C ).
TLR9 CONTRIBUTES TO THE INCREASED SUSCEPTIBILITY OF miR-223KO MICE TO APAP-INDUCED INFLAMMATORY AND NEUTROPHILIC RESPONSES
Previous studies have reported that hepatocyte damage induced by APAP can trigger a sterile inflammatory response through release of damage-associated molecular patterns, such as DNAs, which activate neutrophils by targeting TLR9. (10, 11) To investigate whether TLR9 is also involved in the increased (Fig. 4 and Supporting Fig. S9 ). The above data suggest that miR-223KO mice are more susceptible to APAP-induced liver injury and inflammation dependent on TLR9 in vivo. Next, we wondered whether miR-223 regulates TLR9-mediated induction of inflammatory mediators in neutrophils. To answer this question, bone marrow neutrophils from WT and miR-223KO mice were isolated and treated with the TLR9 agonist, ODN 1585 in vitro. Expression of many inflammatory mediators were significantly higher in neutrophils from miR-223KO mice after TLR9 agonist stimulation compared to those from WT mice (Fig. 5A and Supporting Fig. S10 ). In addition, expression of TLR9 and its downstream genes (IRAK1, TNF receptorassociated factor [TRAF] 3, and TRAF6) were also up-regulated in bone marrow neutrophils from miR-223KO mice, but not in WT neutrophils, 6 hours after TLR9 ligand treatment (Fig. 5B) .
Because NF-jB is a key transcription factor that controls the expression of various inflammatory mediators, and IjB kinase a (IKKa), which plays a key role in activating NF-jB, (38) is a known downstream target of miR-223, (39) we hypothesized that miR-223 may inhibit inflammation by regulating IKKa/NF-jB signaling. By using a bioinformatics approach, we confirmed that IKKa contains the potential target sequence of miR-223 (Fig. 5C ). Luciferase reporter assay further unveiled that transfection of miR-223 mimics significantly decreased luciferase activity from WT-IKKa-3 0 UTR construct, but not from mutantIKKa-3 0 UTR, in 293T cells (Fig. 5D ) and in dHL-60 cells (Supporting Fig. S11 ). Western blotting analysis revealed that expression of IKKa protein was higher in liver and bone marrow neutrophils from miR-223KO mice, compared to those from WT mice, whereas expression of p65 protein was comparable between these two groups (Fig. 5E) . Interestingly, although IKKa protein levels were higher in liver and neutrophils from miR-223KO mice than those from WT neutrophils, expression of IKKa mRNA was comparable in WT and miR-223 mice (Supporting Fig. S12) .
To further explore the other downstream targets of miR-223, we used the miRBase database (40) and identified several predicted miR-223 targeted genes and subsequently performed PCR analyses of these genes in liver and bone marrow neutrophils. Expression of many of these miR-223 targeted genes was comparable in WT and miR-223KO mice, except the upregulation of signal transducer and activator of transcription 3 (STAT3) and the down-regulation of NLR family pyrin domain-containing 3 (NLRP3; NACHT, LRR, and PYD domains-containing protein 3 [NALP3]; Supporting Fig. S12 ). NALP3 is a component of the inflammasome, thus down-regulation of NLRP3 does not explain the enhanced proinflammatory functions in miR-223KO neutrophils, so NLRP3 was not further examined. STAT3 in neutrophils is known to promote inflammation.
(41) Therefore, we examined STAT3 protein expression. Surprisingly, STAT3 protein expression was not up-regulated in liver or neutrophils from miR-223KO mice compared to those from WT mice, suggesting that STAT3 may not contribute to the anti-inflammatory function of miR-223. Future proteomic analyses are required to identify miR-223 direct or indirect target genes in addition to IKKa that contribute to the anti-inflammatory function of miR-223.
miR-223 DOWN-REGULATES IKKa PROTEIN EXPRESSION IN NEUTROPHILS
To further confirm whether miR-223 regulated IKKa expression, dHL-60 cells were transfected with miR-223 mimics or miR-223 inhibitor. miR-223 expression was significantly increased after transfection with miR-223 mimics, but was markedly down-regulated after transfection with miR-223 inhibitor for 24 or 48 hours in dHL-60 cells (Supporting Fig. S13A ), confirming that transfection was effective. Figure 6A shows that overexpression of miR-223 significantly diminished TLR9 agonist-mediated up-regulation of IL-6, MIP1a, and MIP-1b expression in neutrophils. More important, overexpression of miR-223 decreased the level of IKKa protein (Fig. 6B) . In addition, TLR9 agonist ODN 2216 activation of NF-jB (p-p65) at the 30-minute time point was markedly suppressed in miR-223 mimics-transfected cells compared to that in nonspecific miRNA (NS-miRNA)-treated cells (Fig. 6B) . Interestingly, expression of IKKa mRNA was not altered by miR-223 mimics (Supporting Fig. S13B) .
Furthermore, we examined the effects of miRNA-223 inhibitor treatment on TLR9 signaling in HL-60 cells. Our data show that inhibition of miR-223 significantly promoted TLR9 agonist-mediated up-regulation of IKKa protein expression (Fig. 6C) as well as mRNA expression of IL-6, MIP-1a, and MIP-1b in dHL-60 cells (Supporting Fig. S13C ). Finally, treatment with miR-223 mimics attenuated TLR9 agonist-mediated NF-jB p65 activation, whereas treatment with miR-223 inhibitor augmented NF-jB activity (Fig. 6D) .
UP-REGULATION OF miR-223 IN NEUTROPHILS AFTER APAP-INDUCED LIVER INJURY DEPENDS ON mtDNA/TLR9 AND NF-jB ACTIVATION
Previous studies have well documented that activation of TLR9 partially contributes to APAP-induced liver injury and inflammation. (7, 8) Here, we also confirmed that TLR9KO mice have lower levels of serum ALT and neutrophilic NF-jB activity than WT mice post-APAP injection (Supporting Fig. S14A,B) . Interestingly, blockage of TLR9 with ODN 2088 also significantly reduced APAP-mediated up-regulation of miR-223 expression in neutrophils isolated from liver and peripheral blood (Fig. 7A) . Furthermore, APAP-mediated up-regulation of miR-223 in liver neutrophils and peripheral neutrophils was also significantly attenuated in TLR9KO mice (Fig. 7B) . Finally, in vivo administration of the TLR9 agonist, ODN 1585, up-regulated expression of miR-223 in liver neutrophils and peripheral neutrophils (Fig. 7C) .
The above data suggest that TLR9 is involved in miR-223 up-regulation in neutrophils in vivo post-APAP injection. Because mtDNA is a known ligand for TLR9, (42) we hypothesized that mtDNA released by damaged hepatocytes up-regulates miR-223 expression in neutrophils through activation of TLR9. To test this hypothesis, we first measured serum mtDNA. Injection of APAP markedly elevated serum levels of mtDNA, and mtDNA were found in microparticles (MPs) and exosomes with much higher levels in MPs (Fig. 8A) . Then, we treated neutrophils with MPs from APAP-treated hepatocytes and found that MP treatment markedly up-regulated expression of miR-223 in WT neutrophils but not in TLR9KO neutrophils (Fig.  8B) . Moreover, in vitro treatment with the TLR9 agonist, ODN 1585, also markedly up-regulated miR-223 expression in neutrophils (Fig. 8C) . NF-jB is a well-known downstream signal pathway of TLR9 activation.
(43) Thus, we wondered whether TLR9 activation that up-regulates miR-223 is mediated by activation of NF-jB. DNA sequence analyses identified an NF-jB binding site on the miR-223 promoter, and the chromatin immunoprecipitation (ChIP) assay demonstrated that NF-jB was recruited to the promoter region of the miR-223 gene upon TLR9 ligand treatment in neutrophils in vitro (Fig. 8D) .
The above data clearly indicate that mtDNA-TLR9 contributes to miR-223 up-regulation in neutrophils (Figs. 7 and 8 ) and liver inflammation (Fig. 4) , but expression of miR-223 in neutrophils and liver inflammation were only partially reduced in mice treated with the TLR9 antagonist, ODN 2088, or in TLR9KO mice, suggesting that other factors also contribute to liver inflammation and miR-223 up-regulation in neutrophils. Because both TLR3 and TLR4 activations have been implicated in APAP-induced liver injury, (44, 45) we wondered whether activation of these TLRs also up-regulated miR-223 in neutrophils. Surprisingly, treatment with the TLR3 ligand, polyinosinic:polycytidylic acid (poly I:C), and the TLR4 ligand, lipopolysaccharide (LPS), did not alter miR-223 expression in neutrophils (Supporting Fig. S15A ), indicating that TLR3 and TLR4 activation does not contribute to miR-223 up-regulation in neutrophils. Moreover, treatment with IL-6, but not interferongamma (IFN-c) or TNF-a, significantly up-regulated miR-223 expression in neutrophils (Supporting Fig.  S15A ). Collectively, in addition to TLR9 activation, IL-6 also contributes to up-regulated miR-223 expression in neutrophils. Finally, treatment with poly I:C or LPS induced higher levels of IFN-c, MIP-1b, and MIP-2 expression in miR-223 KO neutrophils than in WT neutrophils (Supporting Fig. S15B ), suggesting that miR-223 affects TLR3 and TLR4 signaling.
FIG. 7.
Up-regulation of miR-223 expression in neutrophils during APAP-induced liver injury is mediated by a TLR9-dependent pathway. (A) TLR9 antagonist (ODN 2088) or PBS were injected into WT mice immediately after and at 6 hours after APAP injection. Liver neutrophils and peripheral neutrophils were isolated 24 hours after APAP injection and subjected to miR-223 detection. (B) WT and TLR9KO mice were intraperitoneally injected with 350 mg/kg of APAP dissolved in warm PBS. Liver neutrophils and peripheral neutrophils were isolated 6 hours after APAP injection and subjected to miR-223 detection. (C) WT mice were injected with TLR9 agonist (ODN 1585) or TLR9 control (ODN 1585 control) for 6 hours. MiR-223 expression in liver neutrophils and peripheral neutrophils was measured. Values represent means 6 SEM (n 5 8 for panel A and n 5 7 for panels B,C). *P < 0.05; ***P < 0.001.
Discussion
During APAP-induced liver injury, necrotic hepatocytes release mtDNA, which is known to promote neutrophilic inflammation through activation of TLR9, (7, 8) also inducing a feedback inhibitory pathway to prevent neutrophil overactivation by upregulating miR-223 expression and subsequently terminating liver inflammation and injury (summarized in Fig. 8E) .
Numerous previous studies reported that during APAP-induced liver injury, a large number of miRNAs were elevated in serum in mice and patients, and most of these miRNAs are derived from hepatocytes. (17) (18) (19) (20) (21) In the current article, we demonstrated that neutrophilspecific miR-223 is highly elevated in serum and in neutrophils in mice post-APAP injection. Furthermore, we provided several lines of evidence suggesting that up-regulation of miR-223 in neutrophils post-APAP injection is partially dependent on TLR9. First, blockage of TLR9 with TLR9 antagonist treatment or disruption of the TLR9 gene diminished APAP-mediated up-regulation of miR-223 in neutrophils. Second, activation of TLR9 with the TLR9 agonist up-regulated expression of miR-223 in neutrophils in vitro and in vivo. Finally, ChIP assays identified an NF-jB binding site on the miR-223 promoter in TLR9 agonist-treated neutrophils, providing a mechanistic link between TLR9 activation and miR-223 up-regulation in neutrophils. Interestingly, deletion of the TLR9 gene only partially abolished miR-223 up-regulation in neutrophils from APAP-treated mice. Further studies indicate that other factors (e.g., IL-6) also contribute to miR-223 up-regulation in neutrophils.
miR-223 was first identified as an important regulator for granulopoiesis and homeostasis of mature neutrophils. (22) Subsequently, miR-223 was found to be an important anti-inflammatory mediator in suppressing inflammation. (23, 24) For example, a recent study suggests that miR-223 attenuates lung neutrophil recruitment in tuberculosis by targeting chemoattractants chemokine (C-X-C motif) ligand 2 (MIP-2), chemokine (C-C motif) ligand 3 (MIP-1a), and IL-6. (24) In the current study, we also examined the function and significance of miR-223 up-regulation during APAP-induced liver injury by using miR-223KO mice. Our findings demonstrated that miR-223KO mice were more susceptible to APAP-induced activation of neutrophils and up-regulation of a variety of inflammatory mediators in the liver. In vivo treatment with a TLR9 antagonist reduced expression of many proinflammatory mediators in liver in miR-223KO mice post-APAP injection, whereas in vitro treatment with a TLR9 agonist induced higher levels of several proinflammatory mediators in neutrophils from miR-223KO mice than those from WT mice. Collectively, up-regulation of miR-223 in neutrophils forms a strong inhibitory pathway to prevent neutrophil overactivation during APAP-induced liver damage. Previous studies reported that the anti-inflammatory effect of miR-223 in macrophages is mediated by targeting the NF-jB upstream kinase, IKKa, and subsequently inhibiting NF-jB. (39) In the current article, our findings suggest that miR-223 also targets IKKa in neutrophils, thereby preventing neutrophil overactivation.
Activation of the innate immune system has been suggested to play an important role in APAP-induced liver injury. For example, it was reported that inhibition of neutrophils by injection of anti-Gr-1 antibody or by genetic deletion of ICAM-1 protected against APAP hepatotoxicity, (9, 33) suggesting that neutrophils play an important role in promoting APAP-induced liver injury. However, others believed that neutrophil activation may be a critical event for host defense or injury resolution following APAP overdose, but not a contributing factor to APAP-induced injury. (46) In our studies, we found that serum ALT and AST levels showed no difference between WT and miR-223KO mice at the early stages of APAP injection (3 hours), but miR-223KO mice showed more neutrophil recruitment, systemic inflammation, ROS formation, and higher levels of serum ALT and AST at the later stages of APAP treatment (6 or 24 hours) than WT mice. Moreover, an additional deletion of the ICAM-1 gene reduced hepatic neutrophil infiltration and APAP-induced liver injury in miR-223KO mice. Taken together, all of these findings strongly suggest that neutrophil infiltration likely contributes to liver injury at the later stages of APAP treatment, and miR-223 attenuates liver injury by inhibiting the inflammatory response of neutrophils. In addition, we have previously demonstrated that miR-223 suppresses ROS production of neutrophils through inhibition of the IL-6-p47 phox pathway during alcoholic liver injury. (28) This mechanism is also likely attributed to the increased APAP-induced liver injury in miR-223KO mice.
NETosis is a new form of cell death of activated neutrophils by the release of neutrophil extracellular trap (NET) that are extracelluar scaffolds consisting of nuclear DNA studded with granule proteins, histone, and cytoplasmic antimicrobials, playing a key role in host defense against bacterial infections.
(47) However, the role of NETosis in tissue injury has not been extensively investigated and remains obscure. (48) A recent study showed that development of NET contributes to ischemia/reperfusion-induced liver injury through TLR4-and TLR9-dependent mechanisms. (10) However, whether NETosis and NETs also exacerbate APAP-induced liver injury has not been examined and remains unknown. In the current study, we compared the development of NETs in livers from APAP-treated WT and miR-223KO mice by measuring citrullination of histone 3 (Cit-H3 staining), which is an important step of NETosis. (49) Our data showed that hepatic Cit-H3 staining and protein expression were similar between APAP-treated WT and miR-223KO mice (Supporting Fig. S16 ). In addition, in vitro experiments revealed that there were no differences in NET release from phorbol 12-myristate 13-acetate-stimulated WT and miR-223KO neutrophils (Supporting Fig. S17 ). These findings suggest that miR-223 may not affect NET formation and NETosis post-APAP injection.
Another interesting finding in the current study was that CYP2E1 up-regulation was found in miR-223KO mice compared to WT mice after overnight fasting.
Regulation of CYP2E1 protein expression is quite complex at both transcriptional and posttranslational levels and can be influenced by several inflammatory cytokines and transcription factors, including b-catenin, (30) NFjB, (31) and HNF-1a. (32) Among these transcription factors, only b-catenin protein expression was upregulated in miR-223KO mice, but not in WT mice, after overnight fasting. These results suggest that deletion of miR-223 increases hepatic expression of bcatenin, followed by stimulation of CYP2E1 expression after overnight fasting. However, whether other signaling pathways or factors involved in CYP2E1 regulation in miR-223KO mice after overnight fasting needs to be further studied. Interestingly, without fasting, hepatic expression of CYP2E1 protein was comparable in WT and miR-223KO mice. The mechanisms by which CYP2E1 protein was up-regulated in miR-223KO mice after fasting, but not altered in these mice without fasting, remain unknown. Interestingly, a recent study showed that hepatic CYP2E1 protein expression is similar in na€ ıve WT and natural killer T (NKT) celldeficient mice, but it is significantly higher in NKT cell-deficient mice than WT mice upon fasting. (50) This is probably because compared to WT mice, NKT celldeficient mice produced much higher levels of ketone bodies that up-regulate hepatic expression of CYP2E1 protein. (50) Further studies are needed to identify whether ketone body production is also involved in the up-regulation of hepatic CYP2E1 protein expression in miR-223 KO mice poststarvation.
In summary, on the basis of our findings, we propose a working model in Fig. 8E that neutrophilspecific miR-223 may play a critical role in the control of APAP-induced liver injury by attenuating the inflammatory responses of neutrophils. Thus, miR-223 may be a potential therapeutic target for treatment of APAP-induced liver damage.
